APOE and Alzheimer disease: Furthermore, permanent CMBs were shown sensitive markers indicating BBB dysfunction, and the APOE ε4 genotype can significantly increase the prevalence of CMBs (Yates et al., 2014), or promote the AD pathology toward BBB dysfunction by modulating inflammation markers in AD (Riphagen et al., 2020).